The development of a new multispectral fluorescence imaging system by a team of researchers headed by Greek Professor Vasilis Ntziachristos, Head of Biological Imaging at the Technical University of Munich and Helmholtz Centre, Germany, gives hope to women suffering from ovarian cancer.
A team of surgeons has already performed 10 surgeries as part of the first phase of the clinical trial to evaluate the new technology aiding surgeons in the exact removal of malignant tissue from ovarian cancer patients, which might otherwise have been left undetected and not removed due to their small size, thus causing the reappearance of cancer.
According to Nature Publishing Group, the paper detailing the study was published in the medical journal “Nature Medicine”, in the British “The Guardian” and in “New Scientist”. Greek representatives in this innovative scientific venture were besides Dr. Ntziachristos, his associates Mr. Giorgos Themelis and Mr. Athanasios Sarantopoulos (both working at the Technical University of Munich).
Phillip Low, the Ralph C. Corely distinguished Professor of Chemistry who invented the technology and Gooitzen van Dam, a professor and surgeon at the University of Groningen in The Netherlands where the surgeries took place, are two more scientist who have contributed in the whole effort.